Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy.

Ruggeri, M

Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy. [electronic resource] - Applied health economics and health policy Aug 2017 - 479-490 p. digital

Publication Type: Journal Article

1179-1896

10.1007/s40258-017-0311-4 doi


Antiviral Agents--economics
Cost-Benefit Analysis
Guanine--analogs & derivatives
Health Care Costs--statistics & numerical data
Hepatitis B, Chronic--drug therapy
Humans
Italy--epidemiology
Markov Chains
Quality-Adjusted Life Years
Tenofovir--economics
Treatment Outcome